Until now, we have operated in stealth mode while we were developing this revolutionary way to sequence DNA and RNA. You’ll hear more from us in the coming months.

Martin Huber, CEO, Quantapore

We are excited to support Martin and his highly experienced technical team … to further develop this cutting edge technology for the NGS market.

Mirko Scherer, Managing Partner, TVM Capital